LSD microdose trial for acute pain relief reports “remarkable” results

by EmpathiCSubstanceS | Nov 7, 2020 | Iboga, LSD

An incredible, first-of-its-kind trial testing the pain-killing properties of LSD microdoses has delivered the compelling suggestion that tiny, non-psychedelic doses of this infamous drug could serve as an effective analgesic. Back in the 1960s, during the original...

Landmark clinical trial exploring LSD-MDMA combo to begin late 2020

by EmpathiCSubstanceS | Nov 7, 2020 | Iboga, LSD

sychedelic pharmaceutical company MindMed is set to conduct a novel Phase 1 clinical trial exploring the subjective effects of combining LSD with MDMA. The primary goal of the prospective study is to investigate whether MDMA, a drug known to induce feelings of...

LSD: new scientific study shows microdosing elevates mood and cognition

by EmpathiCSubstanceS | Nov 7, 2020 | Iboga, LSD

Neuropsychologists at The Netherlands’ Maastricht University and their colleagues report that microdoses of LSD can increase mood and cognition. In their double-blind, placebo-controlled study of 24 participants, the researchers administered doses of 0-20...

Phase 2 Clinical Trial of LSD for “Suicide Headaches” Begins Treating Patients

by EmpathiCSubstanceS | Nov 7, 2020 | Iboga, LSD

MindMed Is Collaborating on a Phase 2 Clinical Trial of LSD For Cluster Headaches with University Hospital Basel’s Liechti Lab BASEL, Switzerland, June 8, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMEDOTCQB: MMEDF), is supporting and...

Cooperative Weed: Can A Democratic Workplace Revolutionize Legal Cannabis?

by EmpathiCSubstanceS | Nov 7, 2020 | Cannabis Marijuana

Can worker-owned cooperatives and crowdfunding create a better cannabis industry for both consumers and businesses? This was the question posed by two Massachusetts cannabis veterans Sonia Erika and Ross Bradshaw during the recent Students for Sensible Drug...